Product NDC: | 0703-6801 |
Proprietary Name: | Medroxyprogesterone Acetate |
Non Proprietary Name: | medroxyprogesterone acetate |
Active Ingredient(s): | 150 mg/mL & nbsp; medroxyprogesterone acetate |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-6801 |
Labeler Name: | Teva Parenteral Medicines, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076553 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040914 |
Package NDC: | 0703-6801-04 |
Package Description: | 25 VIAL in 1 TRAY (0703-6801-04) > 1 mL in 1 VIAL |
NDC Code | 0703-6801-04 |
Proprietary Name | Medroxyprogesterone Acetate |
Package Description | 25 VIAL in 1 TRAY (0703-6801-04) > 1 mL in 1 VIAL |
Product NDC | 0703-6801 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | medroxyprogesterone acetate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20040914 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc |
Substance Name | MEDROXYPROGESTERONE ACETATE |
Strength Number | 150 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |